UA26400C2 - Спосіб одержаhhя похідhого ерголіhу - Google Patents

Спосіб одержаhhя похідhого ерголіhу

Info

Publication number
UA26400C2
UA26400C2 UA93003963A UA93003963A UA26400C2 UA 26400 C2 UA26400 C2 UA 26400C2 UA 93003963 A UA93003963 A UA 93003963A UA 93003963 A UA93003963 A UA 93003963A UA 26400 C2 UA26400 C2 UA 26400C2
Authority
UA
Ukraine
Prior art keywords
formula
ergolich
ergolin
derivative
obtaining derivative
Prior art date
Application number
UA93003963A
Other languages
English (en)
Russian (ru)
Inventor
Іларіа Кандіані
Илариа Кандиани
Уолтер Кабрі
Уолтер Кабри
Анжело Бедескі
Анжело Бедески
Франко Заріні
Франко Зарини
Original Assignee
Фарміталіа Карло Ерба С.Р.Л.
Фармиталиа Карло Эрба С.Р.Л.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фарміталіа Карло Ерба С.Р.Л., Фармиталиа Карло Эрба С.Р.Л. filed Critical Фарміталіа Карло Ерба С.Р.Л.
Publication of UA26400C2 publication Critical patent/UA26400C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Psychology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Emergency Protection Circuit Devices (AREA)
  • Control Of Electric Motors In General (AREA)

Abstract

Винахід стосується способу одержання похідного ерголіну формули (l): де R1 представляє етильну групу, R2 представляє диметиламінопропільну групу (CH3)2N(CH2)3, R3 представляє алліл, R4 і R5 представляють атом водню. Зазначену речовину одержують при взаємодії аміду ерголіну формули (ll) з 1-4 еквівалентами ізоціанату формули (lll): Реакцію проводять в розчиннику, такому як діхлорметан, 1,1-діхлоретан або толуол, при температурі від 35°C до 60°C, у присутності CuCI або CuCI2 і сполуки фосфору, вибраної поміж PPh3, P(n-CIPh)3, P(n-MePh)3 і MePh2P.
UA93003963A 1992-03-12 1993-02-15 Спосіб одержаhhя похідhого ерголіhу UA26400C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929205439A GB9205439D0 (en) 1992-03-12 1992-03-12 Process for the synthesis of ergoline derivatives
PCT/EP1993/000360 WO1993018034A1 (en) 1992-03-12 1993-02-15 Process for the preparation of ergoline derivatives

Publications (1)

Publication Number Publication Date
UA26400C2 true UA26400C2 (uk) 1999-08-30

Family

ID=10712024

Family Applications (1)

Application Number Title Priority Date Filing Date
UA93003963A UA26400C2 (uk) 1992-03-12 1993-02-15 Спосіб одержаhhя похідhого ерголіhу

Country Status (25)

Country Link
US (1) US5382669A (uk)
EP (1) EP0593692B1 (uk)
JP (1) JP3339858B2 (uk)
KR (1) KR100274102B1 (uk)
CN (1) CN1038510C (uk)
AT (1) ATE180783T1 (uk)
AU (1) AU653099B2 (uk)
CA (1) CA2106371C (uk)
CZ (1) CZ281708B6 (uk)
DE (1) DE69325138D1 (uk)
FI (1) FI113473B (uk)
GB (1) GB9205439D0 (uk)
HU (1) HU210407B (uk)
IL (1) IL104973A (uk)
MX (1) MX9301297A (uk)
MY (1) MY109152A (uk)
NO (1) NO302754B1 (uk)
NZ (1) NZ249115A (uk)
PH (1) PH30138A (uk)
RU (1) RU2118323C1 (uk)
SK (1) SK279039B6 (uk)
TW (1) TW215089B (uk)
UA (1) UA26400C2 (uk)
WO (1) WO1993018034A1 (uk)
ZA (1) ZA931720B (uk)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0007308D0 (en) 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Process for preparing crystalline form | of cabergoline
US6696568B2 (en) 2001-04-16 2004-02-24 Finetech Ltd. Process and intermediates for production of cabergoline and related compounds
IL155545A (en) * 2003-04-21 2009-12-24 Finetech Pharmaceutical Ltd Solvate form of cabergoline
HUP0400517A3 (en) * 2004-03-04 2006-05-29 Richter Gedeon Vegyeszet Process for producing cabergoline
GB0409785D0 (en) * 2004-04-30 2004-06-09 Resolution Chemicals Ltd Preparation of cabergoline
FR2877945A1 (fr) * 2004-11-18 2006-05-19 Archemis Sa Procede de la preparation de la cabergoline
EP1858894A1 (en) 2005-03-17 2007-11-28 Synthon Argentina S.A. Improved process for making cabergoline
GB0505965D0 (en) * 2005-03-23 2005-04-27 Resolution Chemicals Ltd Preparation of cabergoline
EP1925616A1 (en) * 2006-10-26 2008-05-28 LEK Pharmaceuticals D.D. Process for the preparation of crystal forms of cabergoline via stable solvates of cabergoline
US7939665B2 (en) * 2007-05-04 2011-05-10 Apotex Pharmachem Inc. Efficient process for the preparation of cabergoline and its intermediates
WO2014078857A1 (en) 2012-11-19 2014-05-22 Regents Of The University Of Minnesota Ergoline derivatives as dopamine receptor modulators

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2103603B (en) * 1981-08-11 1985-04-11 Erba Farmitalia Ergoline derivatives

Also Published As

Publication number Publication date
SK140193A3 (en) 1994-11-09
EP0593692B1 (en) 1999-06-02
HUT66712A (en) 1994-12-28
HU210407B (en) 1995-04-28
KR100274102B1 (ko) 2000-12-15
JP3339858B2 (ja) 2002-10-28
NO934077L (no) 1993-11-11
IL104973A (en) 1997-06-10
ZA931720B (en) 1993-11-01
CA2106371A1 (en) 1993-09-13
GB9205439D0 (en) 1992-04-22
MY109152A (en) 1996-12-31
TW215089B (uk) 1993-10-21
NZ249115A (en) 1995-04-27
AU653099B2 (en) 1994-09-15
CZ281708B6 (cs) 1996-12-11
FI113473B (fi) 2004-04-30
CZ271593A3 (en) 1994-04-13
WO1993018034A1 (en) 1993-09-16
MX9301297A (es) 1993-09-01
NO934077D0 (no) 1993-11-11
DE69325138D1 (de) 1999-07-08
AU3497493A (en) 1993-10-05
CN1076196A (zh) 1993-09-15
IL104973A0 (en) 1993-07-08
US5382669A (en) 1995-01-17
JPH06507648A (ja) 1994-09-01
RU2118323C1 (ru) 1998-08-27
EP0593692A1 (en) 1994-04-27
SK279039B6 (sk) 1998-05-06
NO302754B1 (no) 1998-04-20
PH30138A (en) 1997-01-21
FI934933A0 (fi) 1993-11-08
CN1038510C (zh) 1998-05-27
FI934933A (fi) 1993-11-08
CA2106371C (en) 2003-09-23
ATE180783T1 (de) 1999-06-15

Similar Documents

Publication Publication Date Title
TW341573B (en) New erythromycin derivatives, their preparation process and their use as medicaments
HUP9802859A2 (hu) Acil-amino-szalicilsav-amid-származékok és alkalmazásuk peszticidként
HUP0000079A2 (hu) Indán- és dihidroindolszármazékok
UA26400C2 (uk) Спосіб одержаhhя похідhого ерголіhу
IE821872L (en) Amine derivatives.
CA1266667C (en) ARYLIC TRIAZOLINONES HERBICIDES
IE811682L (en) Arylamines.
KR830001911A (ko) 복소환식화합물 유도체(heterocyclic derivatives)의 제조방법
HUP0100453A1 (hu) Eljárás izokarbamidok előállítására
JPS5535067A (en) Novel urea derivative and its preparation
Harpp et al. Organic sulfur chemistry. 20. Reaction of amines with thiophthalimides. Anomalous formation of a thiooxamide
DK0727423T3 (da) Fremgangsmåde til fremstilling af sulfonylurinstofderivater og mellemprodukter til denne fremgangsmåde
DK182181A (da) Antihypertensivt virksomme lactamer og fremgangsmaade til fremstilling heraf
KR930007905A (ko) 알킬 n-(히드록시알킬)-카바메이트의 제조방법
SU956476A1 (ru) Способ получени 5-амино-1,2,3-тиадиазола
Terpugova et al. Synthesis of N, N-dialkylaminophenylacetylenes
Sosnovsky et al. Synthesis of amidine derivatives of alkylthiosulfuric acids as potential antiradiation agents
IE43602L (en) Benzocycloheptathiophenes
ATE4803T1 (de) Verfahren zur herstellung von substituierten bis- acylhydraziden.
KR960017619A (ko) 2-플루오로시클로프로필아민의 제조 방법 및 신규 시클로프로필아민 유도체류
DK0546875T3 (da) Hidtil ukendt fremgangsmåde til fremstilling af 20-oxo-17-alpha,21-dihydroxyderivater af pregnan og mellemprodukter dertil
ATE139767T1 (de) Verfahren zur herstellung 5-pyrazolomerkaptan- derivate und dessen zwischenprodukte
KR930019621A (ko) 신규 n-(2-할로알카노일옥시)석신이미드 유도체 및 그 제조방법
ES8401094A1 (es) Un procedimiento para la produccion de 1-b-d-arabinofuranosil-5-(2-carboxivinil)uracilo o sus derivados.
KR840006645A (ko) 1-프탈리딜-5-플루오로우라실유도체의 제조방법